Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Short-chain fatty acids: Important components of the gut-brain axis against AD

14 May 2024

Abstract excerpt

Alzheimer's disease (AD) comprises a group of neurodegenerative disorders with some changes in the brain, which could lead to the deposition of certain proteins and result in the degeneration and death of brain cells. Patients with AD manifest primarily as cognitive decline, psychiatric symptoms, and behavioural disorders. Short-chain fatty acids (SCFAs) are a class of saturated fatty acids (SFAs) produced by gut...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Gut microbiota and health
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38749177
DOI: 10.1016/j.biopha.2024.116601

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Short-chain fatty acids: Important components of the gut-brain axis against ADPMID 38749177Read ↗

Dietary Pattern, Gut Microbiota, and Alzheimer’s DiseaseSemantic proximity Read ↗

Microbiota-derived short chain fatty acids promote Aβ plaque depositionSemantic proximity Read ↗

Evaluation of the protective bioactivity and molecular mechanism verification of lactoferrin in an Alzheimer's mouse model with ulcerative enteritisSemantic proximity Read ↗

Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical ModelsSemantic proximity Read ↗

Association Between the Gut Microbiota and Alzheimer’s Disease: An Update on Signaling Pathways and Translational TherapeuticsSemantic proximity Read ↗

Double-side role of short chain fatty acids on host health via the gut-organ axesSemantic proximity Read ↗

Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeuticsSemantic proximity Read ↗

Role of short‐chain fatty acids in host physiologySemantic proximity Read ↗

Mediterranean Diet in Neurodegenerative Diseases: Recent Advances from Gut–Immune–Brain Axis to Multi-Omics Guided Precision NutritionSemantic proximity Read ↗

Gut Brain Axis and Neurodegenerative Diseases. Nutritional Interventions Targeting Gut Microbiome: A Systematic ReviewSemantic proximity Read ↗

The role of gut microbiota in pathogenesis of Alzheimer's diseaseSemantic proximity Read ↗

Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.